Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

SLP

Simulations Plus Inc

Dec 13 • 04:00PM ET

30.93

Dollar change -0.99
Percentage change -3.10	%

Healthcare • Health Information Services • USA • NASD

Peers: VRTX REGN GILD AMGN ACAD BIIB BMRN ALKS NBIX SRPT

| Held by: IJR IWM VTI VXF SPSM IWO IJT SCHA IJS VTWO

Scroll to Statements

Index	RUT	P/E	63.15	EPS (ttm)	0.49	Insider Own	18.02%	Shs Outstand	20.05M	Perf Week	2.66%
Market Cap	601.43M	Forward P/E	26.20	EPS next Y	1.18	Insider Trans	-3.28%	Shs Float	16.45M	Perf Month	-2.83%
Income	9.95M	PEG	4.21	EPS next Q	0.14	Inst Own	77.21%	Short Float	6.10%	Perf Quarter	-3.49%
Sales	70.01M	P/S	8.59	EPS this Y	90.14%	Inst Trans	-4.20%	Short Ratio	4.80	Perf Half Y	-33.71%
Book/sh	9.10	P/B	3.40	EPS next Y	17.14%	ROA	4.97%	Short Interest	1.00M	Perf Year	-24.12%
Cash/sh	1.04	P/C	29.70	EPS next 5Y	15.00%	ROE	5.65%	52W Range	27.07 - 51.22	Perf YTD	-30.88%
Dividend Est.	-	P/FCF	47.17	EPS past 5Y	0.62%	ROI	5.44%	52W High	-39.61%	Beta	0.77
Dividend TTM	0.18 (0.58%)	Quick Ratio	3.26	Sales past 5Y	15.64%	Gross Margin	61.63%	52W Low	14.28%	ATR (14)	1.38
Dividend Ex-Date	Jul 29, 2024	Current Ratio	3.26	EPS Y/Y TTM	0.34%	Oper. Margin	8.76%	RSI (14)	50.49	Volatility	4.86% 4.65%
Employees	247	Debt/Eq	0.01	Sales Y/Y TTM	17.52%	Profit Margin	14.22%	Recom	1.29	Target Price	50.00
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	56.72%	Payout	48.95%	Rel Volume	0.84	Prev Close	31.92
Sales Surprise	-5.24%	EPS Surprise	21.95%	Sales Q/Q	19.42%	Earnings	Oct 23 AMC	Avg Volume	209.12K	Price	30.93
SMA20	1.20%	SMA50	0.51%	SMA200	-20.92%	Trades		Volume	175,656	Change	-3.10%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-24	Initiated	Stephens	Overweight	$39
Jul-29-24	Initiated	KeyBanc Capital Markets	Overweight	$47
Jul-16-24	Initiated	JMP Securities	Mkt Perform
Jun-28-24	Initiated	William Blair	Outperform
May-09-23	Initiated	BTIG Research	Buy	$55
Oct-26-21	Upgrade	Craig Hallum	Hold → Buy	$65 → $53
Jan-12-21	Downgrade	Craig Hallum	Buy → Hold
Oct-16-20	Initiated	Raymond James	Outperform	$95
Sep-08-20	Initiated	Oppenheimer	Outperform	$79
Jan-06-20	Initiated	Craig Hallum	Buy	$40

Nov-26-24 09:55AM	Wall Street Analysts Predict a 56.99% Upside in Simulations Plus (SLP): Here's What You Should Know (Zacks)
Nov-22-24 07:15AM	Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar? (Zacks)
Nov-19-24 08:30AM	Simulations Plus to Participate in the BTIG Digital Health Forum (Business Wire)
Nov-13-24 08:30AM	Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables (Business Wire)
Nov-08-24 09:55AM	How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52% (Zacks)
08:30AM	Loading…
Nov-06-24 08:30AM	Simulations Plus to Participate in the Stephens Annual Investment Conference (Business Wire) +7.76%
Oct-30-24 08:30AM	Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations (Business Wire)
Oct-24-24 10:52AM	Q4 2024 Simulations Plus Inc Earnings Call (Thomson Reuters StreetEvents) -8.89%
03:10AM	Simulations Plus Inc (SLP) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market ... (GuruFocus.com)
Oct-23-24 06:05PM	Simulations Plus (SLP) Surpasses Q4 Earnings Estimates (Zacks)
05:17PM	Simulations Plus: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:06PM	Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results (Business Wire)
Oct-22-24 08:49AM	Simulations Plus (SLP) Fell Due to EBITDA Below Expectations (Insider Monkey)
Oct-09-24 04:06PM	Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date (Business Wire)
Oct-08-24 08:30AM	Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings (Business Wire)
10:28AM	Loading…
Oct-01-24 10:28AM	Improve Demand Lifted Simulations Plus (SLP) (Insider Monkey)
Sep-04-24 07:00PM	Insider Sale: Director and 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc ... (GuruFocus.com)
Aug-28-24 08:30AM	Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-26-24 11:00AM	Simulations Plus (SLP) Restructures Business Unit Post-Acquisitions (Zacks)
Aug-23-24 08:00AM	Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions (Business Wire)
Aug-16-24 02:48AM	Should You Hold Simulations Plus (SLP)? (Insider Monkey)
Aug-09-24 09:23AM	Implied Volatility Surging for Simulations Plus (SLP) Stock Options (Zacks)
Aug-02-24 11:34PM	Insider Sale: Director and 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc ... (GuruFocus.com)
Aug-01-24 08:30AM	Simulations Plus Releases DILIsym X (Business Wire)
Jul-30-24 08:30AM	Simulations Plus Releases ADMET Predictor Version 12 (Business Wire)
Jul-25-24 08:30AM	Simulations Plus to Participate in KeyBancs 25th Annual Technology Leadership Forum (Business Wire)
Jul-20-24 09:25AM	Simulations Plus, Inc. (SLP): One of the Most Profitable Stocks According to Hedge Funds? (Insider Monkey)
Jul-12-24 10:07AM	Simulations Plus (SLP) Ties Up With ICCS for Chemical Safety (Zacks)
Jul-11-24 08:30AM	Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety (Business Wire) +7.44%
Jul-03-24 10:20AM	Simulations Plus (SLP) Q3 Earnings & Revenues Beat Estimates (Zacks) -14.87%
09:29AM	Loading…
09:29AM	Q3 2024 Simulations Plus Inc Earnings Call (Thomson Reuters StreetEvents)
08:02AM	Simulations Plus, Inc. (NASDAQ:SLP) Q3 2024 Earnings Call Transcript (Insider Monkey)
Jul-02-24 08:52PM	SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q3 2024 (InvestorPlace)
04:16PM	Simulations Plus: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:06PM	Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results (Business Wire)
Jun-25-24 10:00AM	Analysts Estimate Simulations Plus (SLP) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jun-20-24 08:30AM	Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit (Business Wire)
Jun-18-24 08:30AM	Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date (Business Wire)
Jun-14-24 12:00PM	Simulations Plus (SLP) Upgraded to Buy: Here's Why (Zacks)
Jun-13-24 09:10AM	Simulations Plus (SLP) Buys Pro-ficiency Holdings for $100M (Zacks)
Jun-12-24 08:58AM	QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus (Business Wire) +6.92%
08:00AM	Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum (Business Wire)
Jun-04-24 07:00PM	Insider Sale: Director and 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc ... (GuruFocus.com)
May-22-24 08:30AM	Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference (Business Wire)
May-16-24 01:18PM	Simulations Plus (SLP) Launches GPX to Advance PBPK Modeling (Zacks)
May-15-24 07:01PM	Director Daniel Weiner Sells 3,000 Shares of Simulations Plus Inc (SLP) (GuruFocus.com)
08:30AM	Simulations Plus Releases GastroPlus X, The Next Generation PBPK/PBBM Modeling & Simulation Software (Business Wire)
May-08-24 09:15PM	Director Daniel Weiner Sells 3,250 Shares of Simulations Plus Inc (SLP) (GuruFocus.com)
May-03-24 02:28AM	Insider Sale at Simulations Plus Inc (SLP): Director and 10% Owner Walter Woltosz Sells 20,000 ... (GuruFocus.com)
Apr-12-24 01:53PM	New AI Bot Predicts These 7 Stocks Will Mint Millionaires (InvestorPlace)
Apr-08-24 09:06AM	Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA (Zacks)
Apr-04-24 09:27AM	Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript (Insider Monkey) +23.61%
08:30AM	U.S. FDA Renews DILIsym Software Licenses for 7th Year (Business Wire)
06:34AM	Simulations Plus (SLP) Q2 Earnings & Revenues Beat Estimates (Zacks)
06:24AM	Q2 2024 Simulations Plus Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-03-24 08:53PM	SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
05:32PM	Simulations Plus Inc (SLP) Aligns with EPS Projections and Maintains Full-Year Guidance (GuruFocus.com)
05:20PM	Simulations Plus (SLP) Q2 Earnings and Revenues Surpass Estimates (Zacks)
04:34PM	Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results (Business Wire)
04:21PM	Simulations Plus: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
Apr-02-24 07:24AM	Simulations Plus (SLP) to Report Q2 Earnings: What's in Store? (Zacks)
Mar-20-24 04:06PM	Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date (Business Wire)
Mar-13-24 08:30AM	Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum (Business Wire)
Mar-05-24 05:01PM	Director and 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc (SLP) (GuruFocus.com)
08:30AM	Simulations Plus and the University of Bath Awarded New FDA Grant (Business Wire)
Feb-23-24 05:14AM	5 Most Valuable Digital Health Companies In The US (Insider Monkey)
Feb-15-24 08:30AM	Simulations Plus Extends Collaboration with Major Toxicology Research Agency (Business Wire)
Feb-13-24 09:15AM	Simulations Plus Launches Corporate Development Initiative (Business Wire) -8.63%
Feb-06-24 08:30AM	Simulations Plus to Participate in Upcoming Healthcare Conferences (Business Wire)
Feb-05-24 11:30PM	Simulations Plus Inc Director and 10% Owner Walter Woltosz Sells 20,000 Shares (GuruFocus.com)
09:35AM	Down -5.35% in 4 Weeks, Here's Why You Should You Buy the Dip in Simulations Plus (SLP) (Zacks)
Jan-30-24 08:30AM	Simulations Plus Releases GastroPlus Version 9.9 (Business Wire)
Jan-11-24 09:55AM	Bears are Losing Control Over Simulations Plus (SLP), Here's Why It's a 'Buy' Now (Zacks)
Jan-09-24 08:30AM	Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant (Business Wire)
Jan-05-24 03:02AM	Insider Sell: Director, 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc (SLP) (GuruFocus.com)
Jan-04-24 08:42AM	Simulations Plus, Inc. (NASDAQ:SLP) Q1 2024 Earnings Call Transcript (Insider Monkey) -5.00%
06:54AM	Q1 2024 Simulations Plus Inc Earnings Call (Thomson Reuters StreetEvents)
Jan-03-24 11:26PM	Simulations Plus Inc (SLP) Reports Strong Start to Fiscal 2024 with Robust Revenue Growth (GuruFocus.com)
09:51PM	SLP Stock Earnings: Simulations Plus Meets EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:13PM	Simulations Plus: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:06PM	Simulations Plus Reports First Quarter Fiscal 2024 Financial Results (Business Wire)
04:05PM	Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth (Business Wire)
Jan-02-24 05:27PM	FOMC meeting minutes, job openings, earnings: What to watch (Yahoo Finance Video)
Dec-29-23 08:55AM	Simulations Plus (SLP) to Report Q1 Earnings: What's in Store? (Zacks)
Dec-20-23 08:30AM	Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date (Business Wire)
Dec-06-23 03:04AM	Insider Sell Alert: Director Walter Woltosz Sells 60,000 Shares of Simulations Plus Inc (SLP) (GuruFocus.com)
Nov-14-23 08:00AM	Simulations Plus Outlines Paths to Win at 2023 Investor Day (Business Wire) +5.21%
Nov-08-23 08:30AM	ISoP New Board of Trustees Members Announced (Business Wire)
Nov-03-23 07:03PM	Insider Sell: Director, 10% Owner Walter Woltosz Sells 60,000 Shares of Simulations Plus Inc (GuruFocus.com)
Oct-31-23 08:30AM	Simulations Plus to Host Investor Day on Tuesday, November 14th (Business Wire)
Oct-26-23 12:29PM	Simulations Plus, Inc. (NASDAQ:SLP) Q4 2023 Earnings Call Transcript (Insider Monkey) -14.70%
10:07AM	Q4 2023 Simulations Plus Inc Earnings Call (Thomson Reuters StreetEvents)
Oct-25-23 06:36PM	Simulations Plus Inc (SLP) Reports 11% Revenue Increase in Fiscal 2023 (GuruFocus.com)
05:23PM	Simulations Plus: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:06PM	Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results (Business Wire)
Oct-11-23 04:06PM	Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call (Business Wire)
Sep-21-23 08:30AM	Simulations Plus Receives New FDA Grant Award (Business Wire)
Sep-07-23 08:30AM	Simulations Plus Hosts First-of-its-Kind Virtual Summer Camp for Students and Professors (Business Wire)
Aug-24-23 08:30AM	Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS) (Business Wire)
Aug-15-23 08:30AM	Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment (Business Wire)

Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WOLTOSZ WALTER S	Director	Dec 02 '24	Sale	31.76	20,000	635,200	3,442,584	Dec 03 05:35 PM
LaVange Lisa	Director	Dec 02 '24	Sale	31.88	650	20,722	7,150	Dec 03 05:32 PM
LISA LAVANGE	Officer	Dec 02 '24	Proposed Sale	31.77	650	20,650		Dec 02 04:34 PM
WOLTOSZ WALTER S	Director	Nov 01 '24	Sale	27.66	20,000	553,200	3,462,584	Nov 05 08:02 AM
WOLTOSZ WALTER S	Director	Oct 01 '24	Sale	31.26	20,000	625,200	3,481,592	Oct 02 04:34 PM
WEINER DANIEL L	Director	Sep 27 '24	Sale	31.54	750	23,655	6,994	Oct 01 04:30 PM
VIRGINIA EVANS WOLTOSZ & WALTE	Director	Oct 01 '24	Proposed Sale	32.02	60,000	1,921,200		Oct 01 04:29 PM
DANIEL LEE WEINER	Director	Sep 27 '24	Proposed Sale	31.07	750	23,302		Sep 27 04:24 PM
BRETT ALYN HOWELL	Officer	Sep 18 '24	Proposed Sale	32.00	12,200	390,400		Sep 18 04:17 PM
Fiedler-Kelly Jill	Business Unit President	Sep 09 '24	Option Exercise	9.71	2,250	21,848	68,867	Sep 10 04:45 PM
WOLTOSZ WALTER S	Director	Sep 03 '24	Sale	35.18	20,000	703,677	3,501,592	Sep 04 04:11 PM
LaVange Lisa	Director	Sep 03 '24	Sale	35.95	650	23,368	6,808	Sep 04 04:09 PM
LISA LAVANGE	Director	Sep 03 '24	Proposed Sale	36.25	650	23,562		Sep 03 04:29 PM
WOLTOSZ WALTER S	Director	Aug 01 '24	Sale	39.63	20,000	792,547	3,521,592	Aug 02 04:19 PM
WOLTOSZ WALTER S	Director	Jul 01 '24	Sale	46.71	20,000	934,227	3,540,857	Jul 02 04:10 PM
WEINER DANIEL L	Director	Jun 28 '24	Sale	49.32	750	36,990	7,009	Jul 01 04:24 PM
WOLTOSZ WALTER S	Director	Jun 03 '24	Sale	46.25	20,000	924,978	3,560,857	Jun 04 05:04 PM
LaVange Lisa	Director	Jun 03 '24	Sale	48.26	650	31,369	6,723	Jun 04 05:03 PM
LaVange Lisa	Director	May 14 '24	Sale	50.00	500	25,000	7,373	May 15 04:56 PM
WEINER DANIEL L	Director	May 14 '24	Option Exercise	34.23	2,000	68,460	10,759	May 15 04:53 PM
WEINER DANIEL L	Director	May 14 '24	Sale	50.13	3,000	150,390	7,759	May 15 04:53 PM
WEINER DANIEL L	Director	May 07 '24	Option Exercise	34.23	2,000	68,460	12,009	May 08 04:42 PM
WEINER DANIEL L	Director	May 07 '24	Sale	48.31	3,250	157,008	8,759	May 08 04:42 PM
LaVange Lisa	Director	May 07 '24	Sale	48.30	650	31,395	7,873	May 08 04:39 PM
WOLTOSZ WALTER S	Director	May 01 '24	Sale	45.95	20,000	918,984	3,580,857	May 02 04:37 PM
WOLTOSZ WALTER S	Director	Apr 01 '24	Sale	39.94	20,000	798,867	3,600,195	Apr 02 04:32 PM
WOLTOSZ WALTER S	Director	Mar 01 '24	Sale	41.41	20,000	828,240	3,620,195	Mar 05 04:22 PM
WOLTOSZ WALTER S	Director	Feb 01 '24	Sale	38.02	18,945	720,237	3,641,250	Feb 05 05:04 PM
WOLTOSZ WALTER S	Director	Feb 02 '24	Sale	37.64	1,055	39,710	3,640,195	Feb 05 05:04 PM
Paglia John Kenneth	Director	Jan 04 '24	Sale	43.74	1,000	43,740	2,097	Jan 04 06:37 PM
WOLTOSZ WALTER S	Director	Jan 02 '24	Sale	44.46	20,000	889,200	3,659,403	Jan 04 06:36 PM
DiBella John Anthony II	Business Unit President	Dec 22 '23	Sale	45.16	5,411	244,361	74,429	Dec 26 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SLP

Simulations Plus Inc

Upgrade your FINVIZ experience